Eduardo Rodriguez Almaraz
SENIOR CRC SUPERVISOR
Neurological Surgery
School of Medicine

Education & Training

Show all (3) Hide

• PhD Epidemiology and Translational Science (DE: Computational Precision Health) University of California, San Francisco 03/2025
• MAS Clinical Research University of California, San Francisco 06/2019
• MD Medicine National Polytechnic Institute 11/2012

Interests

Show all (9) Hide

• Neuro Oncology
• Oncology Clinical Trials
• Precision Medicine
• Machine Learning
• Quality of Life
• Cannabis and glioma
• SMART studies
• AI in Cancer
• Cancer genetics

Videos

Show all (1) Hide

• Medical Cannabis for Those Living With Brain Tumors: What Do We Really Know? (youtube.com)

Grants and Projects

Show all (3) Hide

• Identification of actionable mutations in IDH-mutant gliomas using next generation sequencing (UCSF 500), UCSF - Molecular oncology program, 2022-2023
• , Sullivan Grant, 2020-2022
• Impact of Cannabis and synthetic cannabinoid use on quality of life of patients with central nervous system tumors (ICANCNS-QoL), , 2018

Publications (15)

Top publication keywords:
PrognosisBiomarkers, TumorQuality of LifeGliomaDNA Repair EnzymesBrain NeoplasmsSurvival RatePolymorphism, Single NucleotideDNA RepairCannabidiolCannabisAntineoplastic Agents, AlkylatingGerm-Line MutationCannabinoidsDNA Damage

• Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient community.
  Neuro-oncology practice 2025 Hoffer N, Rodriguez Almaraz E, Fetting L, Taylor J, Chang S
• Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.
  Neuro-oncology 2025 Guerra G, Wendt G, McCoy L, Hansen HM, Kachuri L, Molinaro AM, Rice T, Guan V, Capistrano L, Hsieh A, Kalsi V, Sallee J, Taylor JW, Clarke JL, Almaraz ER, Wiencke JK, Eckel-Passow JE, Jenkins RB, …
• Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
  Neuro-oncology advances 2025 Rodriguez Almaraz E, Guerra GA, Al-Adli NN, Young JS, Dada A, Quintana D, Taylor JW, Oberheim Bush NA, Clarke JL, Butowski NA, de Groot J, Pekmezci M, Perry A, Bollen AW, Scheffler AW, Glidden DV, …
• Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group.
  Neuro-oncology practice 2024 Boele FW, Hertler C, Sherwood P, Cachia D, Dirven L, Young JS, Walbert T, Stockdill M, Rodriguez Almaraz E, Piil K
• Evaluating large language models as agents in the clinic.
  NPJ digital medicine 2024 Mehandru N, Miao BY, Almaraz ER, Sushil M, Butte AJ, Alaa A

Show all (10 more) Hide

• Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis).
  Current treatment options in oncology 2023 Rodriguez-Almaraz JE, Butowski N
• Neuro-Oncology
  Retroelement expression in glioma tumors exhibits subtype specific patterns 2022 JE Rodriguez Almaraz, G Guerra, G Wendt, S Chang, S S Francis
• Neuro-Oncology
  BIOM-07. Quantitative MGMT Promoter Methylation Index indicates a non-linear prognostic effect in glioblastoma, suggesting that use of optimal cutoff points may be clinically disadvantageous 2021 Gibson, D., Ravi, A., Rodriguez Almaraz E. , Chang, S., Oberheim-Bush, N. A., Taylor, J., Clarke, J., Solomon, D., Scheffler, A., Witte, J., Lambing, H., Berger, M., Okada, H., Chehab, F., & Butowski,…
• Journal of Clinical Oncology
  Pilot trial treating recurrent GBM patients with precision medicine regimens. 2021 Jennifer Leigh Clarke, David Solomon, Nancy Ann Oberheim Bush, Jennifer A. Grabowsky, Cassie Kline, Deanna L. Kroetz, Jennie Webster Taylor, Javier Villanueva-Meyer, Annette Molinaro, David Gibson, …
• A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors
  A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant central nervous system tumors 2020 Eduardo Rodriguez Almaraz, MD, MAS, Susan Chang, MD, Jennifer Clarke, MD, MPH, Nancy Ann Oberheim-Bush, MD, PhD, Jennie Taylor, MD, Robin Buerki, MD, Mitchell Berger, MD, Lydia Zablotska, MD, PhD, …
• PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) with and without Temozolomide in the treatment of Adult Patients with supratentorial low-grade glioma
  PI3K/mTOR Pathway Activation Selected Phase II Study of Everolimus (RAD001) with and without Temozolomide in the treatment of Adult Patients with supratentorial low-grade glioma. 2019 Jennie Taylor, Annette Molinaro, Eduardo Rodriguez Almaraz, Ciara Downey, Joanna Phillips, Nancy Ann Oberheim-Bush, Nicholas Butowski, Susan Chang, Mitchel Berger, Michael Prados, Daphne Haas-Kogan, …
• Impact of cannabis use on quality of life in patients with central nervous system tumors
  Impact of cannabis use on quality of life in patients with central nervous system tumors 2019 J E Rodriguez Almaraz, S M Chang, N A E Oberheim-Bush, J R Clarke, J W Taylor, R A Buerki, M S Berger, N A Butowski
• Clinical experience with short-term-combined formula as pharmacological treatment (extended release) in the management of obesity
  Clinical experience with short-term-combined formula as pharmacological treatment (extended release) in the management of obesity 2014 Morin-Zaragoza R, Rodriguez-Choreno JD, Morales-Suarez MO, Rodriguez Almaraz JE.
• Mexican Contributions to the study of Obesity. Pharmacology chapter
  Mexican Contributions to the study of Obesity. Pharmacology chapter 2014 Leija, Gerardo.
• Possible mechanisms involved in the vasorelaxant effect produced by fenproporex in aortic segments of rats
  Possible mechanisms involved in the vasorelaxant effect produced by fenproporex in aortic segments of rats. 2013 Lopez-Canales JS, Lozano-Cuenca J, Morin-Zaragoza R, Rodriguez Almaraz JE.